Literature DB >> 11493219

Vascular parkinsonism: a distinct, heterogeneous clinical entity.

M Demirkiran1, H Bozdemir, Y Sarica.   

Abstract

OBJECTIVES: The aim of this study was to define the symptoms and signs of suspected vascular parkinsonism (VP) which is still a debatable concept.
MATERIAL AND METHODS: Patients with parkinsonism were grouped into patients with suspected VP and Parkinson's disease (PD) after other causes for secondary parkinsonism, and parkinsonism-plus syndromes were excluded. The clinical features of 16 patients with suspected VP to those of 50 diagnosed with PD were compared. All patients were assessed using unified Parkinson's disease rating scale (UPDRS) and all had cerebral MRIs.
RESULTS: Patients with VP had significantly older onset age and shorter duration of disease with gait disorder as the most frequent initial symptom. All PD patients had satisfactory response to levodopa treatment, whereas only 38% VP patients had satisfactory response to levodopa treatment. Vascular risk factors were more common in VP (81%) than PD (32%). Postural instability, freezing, gait disturbance, pyramidal signs, and postural tremor were significantly more prevalent in patients with VP than in PD. In VP patients these features were more prominent in the lower limbs. Twenty-five percent had acute onset VP. All patients with VP had ischemic lesions, mainly in subcortical white matter, to a lesser extent basal ganglia and brainstem, in their cerebral MRIs, while 70% of PD patients had normal MRIs.
CONCLUSION: The differences in the clinical features support the concept that VP is a distinct clinical entity with heterogeneous clinical, MRI, and possibly pathophysiological features.

Entities:  

Mesh:

Year:  2001        PMID: 11493219     DOI: 10.1034/j.1600-0404.2001.104002063.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  28 in total

1.  The L-dopa response in vascular parkinsonism.

Authors:  J C M Zijlmans; R Katzenschlager; S E Daniel; A J L Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

2.  Imaging of dopamine transporters and D2 receptors in vascular parkinsonism: a report of four cases.

Authors:  M Plotkin; H Amthauer; S Quill; F Marzinzik; F Klostermann; S Klaffke; A Kivi; M Gutberlet; R Felix; A Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2005-02-22       Impact factor: 3.575

3.  Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

Authors:  Chung-Fen Tsai; Ruey-Meei Wu; Yu-Weng Huang; Li-Ling Chen; Ping-Keung Yip; Jiann-Shing Jeng
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.

Authors:  Christina Sundal; Shinsuke Fujioka; Jay A Van Gerpen; Christian Wider; Alexandra M Nicholson; Matt Baker; Elizabeth A Shuster; Jan Aasly; Salvatore Spina; Bernardino Ghetti; Sigrun Roeber; James Garbern; Alex Tselis; Russell H Swerdlow; Bradley B Miller; Anne Borjesson-Hanson; Ryan J Uitti; Owen A Ross; A Jon Stoessl; Rosa Rademakers; Keith A Josephs; Dennis W Dickson; Daniel Broderick; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2013-06-17       Impact factor: 4.891

5.  Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Authors:  Xue-Jun Zhao; Xi-Yuan Niu; He-Yang You; Min Zhou; Xue-Bing Ji; Ying Liu; Lei Wu; Xiao-Ling Ding
Journal:  Curr Med Sci       Date:  2019-10-14

6.  MRI volumetric morphometry in vascular parkinsonism.

Authors:  Vincent Dunet; Jeremy Deverdun; Celine Charroud; Emmanuelle Le Bars; Francois Molino; Sophie Menjot de Champfleur; Florence Maury; Mahmoud Charif; Xavier Ayrignac; Pierre Labauge; Giovanni Castelnovo; Frederic Pinna; Alain Bonafe; Christian Geny; Nicolas Menjot de Champfleur
Journal:  J Neurol       Date:  2017-07-01       Impact factor: 4.849

7.  Associations between cerebrovascular risk factors and parkinson disease.

Authors:  Benjamin R Kummer; Iván Diaz; Xian Wu; Ashley E Aaroe; Monica L Chen; Costantino Iadecola; Hooman Kamel; Babak B Navi
Journal:  Ann Neurol       Date:  2019-08-29       Impact factor: 10.422

8.  Clinical characteristics of elderly patients with a cautious gait of unknown origin.

Authors:  N Giladi; T Herman; I I Reider-Groswasser; T Gurevich; J M Hausdorff
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

9.  Cognitive Impairment and Basal Ganglia Functional Connectivity in Vascular Parkinsonism.

Authors:  V Dunet; J Deverdun; C Charroud; E Le Bars; F Molino; S Menjot de Champfleur; F Maury; M Charif; X Ayrignac; P Labauge; G Castelnovo; F Pinna; A Bonafe; C Geny; N Menjot de Champfleur
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-14       Impact factor: 3.825

10.  Doppler sonography characteristics of vertebrobasilar circulation in patients with Parkinson's disease.

Authors:  Mirjana Vidović; Osman Sinanović; Dzevdet Smajlović; Adnan Burina; Josip Hudić
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.